English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNIH’s RADx Tech committed resources in early 2022 for increased accessibility of COVID-19 home tests. The RADx Tech Accessibility Program subsequently invited collaboration from advocacy organizations to contribute to design insights and is a first step that will help manufacturers address the gap in accessible test availability.
Tag: Diagnostic Test
AnX Robotica Partners with GastroGPO, a Specialty Networks Company
AnX Robotica Corporation (www.anxrobotics.com), the developer and manufacturer of the NaviCam® Magnetically Controlled Capsule Endoscopy System (MCCE), is pleased to announce a partnership with GastroGPO, a Specialty Networks Company.
Rapid Ebola diagnosis may be possible with new technology
A new tool can quickly and reliably identify the presence of Ebola virus in blood samples, according to a study by researchers at Washington University School of Medicine in St. Louis and colleagues at other institutions.
New wiki on salivary proteins may transform diagnostic testing and personalized medicine
To improve the development of new saliva-based diagnostic tests and personalized medicine, the National Institute of Dental and Craniofacial Research (NIDCR) has supported the development of the Human Salivary Proteome Wiki, the first public platform that catalogs and curates data on each of the thousands of proteins within our saliva.
RADx diversifies COVID-19 test portfolio with four new contracts, including one to detect variants
NIH has awarded four additional contracts for the development and scaled-up manufacturing of new COVID-19 diagnostic testing technologies through its Rapid Acceleration of Diagnostics Tech (RADx) initiative. The awards total $29.3 million and will help increase testing capacity for COVID-19.
NIH continues to boost national COVID-19 testing capacity
NIH today announced $129.3 million in scale-up and manufacturing support for a new set of COVID-19 testing technologies as part of its RADx initiative. NIH is awarding contracts to nine companies for technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can return results within 24 hours.
Rutgers Researchers Awarded $20 Million NIH Grant to Find New Ways to Diagnose Tuberculosis
Rutgers researchers have been awarded a $20 million grant by the National Institutes of Health (NIH) to evaluate new point of care tests that would diagnose Tuberculosis, the number one cause of deaths worldwide due to an infectious disease.
NIH mobilizes national innovation initiative for COVID-19 diagnostics
NIH today announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic.